Evista Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With Osteopenia: an 1-year Randomized Controlled Trial
Condition:   Postemenopusal Women With Osteopenia Interventions:   Drug: Raloxifene plus cholecalciferol;   Drug: Cholecalciferol Sponsor:   Yonsei University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2022 Category: Research Source Type: clinical trials

Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With Osteopenia
Condition:   Postemenopusal Women With Osteopenia Interventions:   Drug: Raloxifene plus cholecalciferol;   Drug: Cholecalciferol Sponsor:   Yonsei University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2022 Category: Research Source Type: clinical trials

Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With Osteopenia: an 1-year Randomized Controlled Trial
Condition:   Postemenopusal Women With Osteopenia Interventions:   Drug: Raloxifene plus cholecalciferol;   Drug: Cholecalciferol Sponsor:   Yonsei University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2022 Category: Research Source Type: clinical trials

Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With Osteopenia
Condition:   Postemenopusal Women With Osteopenia Interventions:   Drug: Raloxifene plus cholecalciferol;   Drug: Cholecalciferol Sponsor:   Yonsei University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2022 Category: Research Source Type: clinical trials

Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.
Condition:   SARS CoV 2 Infection Interventions:   Drug: Raloxifene;   Other: Placebo Sponsor:   Dompé Farmaceutici S.p.A Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2021 Category: Research Source Type: clinical trials